Cogent Biosciences (COGT) EBT Margin (2017 - 2020)
Cogent Biosciences (COGT) recorded quarterly EBT Margin of 18325.64% in Q3 2020, down 1207.56% quarter-over-quarter from 1401.52% in Q2 2020, and down 1714868.0% on a YoY basis from N/an in Q4 2019.
Cogent Biosciences (COGT) EBT Margin (2017 - 2020) Analysis & Trends
Cogent Biosciences' EBT Margin history runs 4 years deep, the most recent figure standing at 18325.64% for Q3 2020.
- In Q3 2020, EBT Margin fell 1714868.0% year-over-year to 18325.64%; the TTM figure through Dec 2020 stood at 1042.5% (down 90066.0% YoY), while the FY2020 annual figure was 1042.5%, down 90066.0% from the prior year.
- EBT Margin was 18325.64% for Q3 2020 at Cogent Biosciences, down from 1401.52% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 15.05% in Q4 2019 to a low of 18325.64% in Q3 2020.
- Historically, EBT Margin has averaged 1634.34% across 4 years, with a median of 327.26% in 2017.
- Biggest YoY gain for EBT Margin was 29626 bps in 2020; the steepest drop was 1714868 bps in 2020.
- A 4-year view of EBT Margin shows it stood at 319.41% in 2017, then grew by 29 bps to 225.91% in 2018, then surged by 107 bps to 15.05% in 2019, then plunged by 121857 bps to 18325.64% in 2020.
- The last three EBT Margin figures came in at 18325.64% (Q3 2020), 1401.52% (Q2 2020), and 86.67% (Q1 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 6.40% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Cogent Biosciences | 5.09 Bn | 4.22 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -18,325.64% |
| Jun 30, 2020 | -1,401.52% |
| Mar 31, 2020 | -86.67% |
| Dec 31, 2019 | 15.05% |
| Sep 30, 2019 | -1,176.96% |
| Jun 30, 2019 | -335.12% |
| Mar 31, 2019 | -382.93% |
| Dec 31, 2018 | -225.91% |
| Sep 30, 2018 | -497.85% |
| Jun 30, 2018 | -551.02% |
| Mar 31, 2018 | -311.04% |
| Dec 31, 2017 | -319.41% |
| Sep 30, 2017 | -303.30% |
| Jun 30, 2017 | -285.52% |
| Mar 31, 2017 | -327.26% |